The effects of omega-3 fatty acids supplementation on hemoglobin, hematocrit, and platelet levels of patients with ESRD condition undergoing dialysis

IF 4.7 Q2 IMMUNOLOGY
Zahra Mahmoudi , Zahra Roumi , Seyed Ali Askarpour , Zahra Mousavi , Hanieh Shafaei , Neda Valisoltani , Mahsa Shapouri , Seyed Reza Mirshafaei , Pouya Mirzaee , Khadijeh Abbasi Mobarakeh , Elahe Taghavi Sufiani , Zeinab Motiee Bijarpasi , Zeynab Motiei , Masoud Khosravi , Saeid Doaei , Maryam Gholamalizadeh
{"title":"The effects of omega-3 fatty acids supplementation on hemoglobin, hematocrit, and platelet levels of patients with ESRD condition undergoing dialysis","authors":"Zahra Mahmoudi ,&nbsp;Zahra Roumi ,&nbsp;Seyed Ali Askarpour ,&nbsp;Zahra Mousavi ,&nbsp;Hanieh Shafaei ,&nbsp;Neda Valisoltani ,&nbsp;Mahsa Shapouri ,&nbsp;Seyed Reza Mirshafaei ,&nbsp;Pouya Mirzaee ,&nbsp;Khadijeh Abbasi Mobarakeh ,&nbsp;Elahe Taghavi Sufiani ,&nbsp;Zeinab Motiee Bijarpasi ,&nbsp;Zeynab Motiei ,&nbsp;Masoud Khosravi ,&nbsp;Saeid Doaei ,&nbsp;Maryam Gholamalizadeh","doi":"10.1016/j.jtauto.2024.100233","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Concomitant inflammation may boost the cardiovascular complications in end-stage renal disease (ESRD) patients undergoing hemodialysis (HD). Omega-3 fatty acids may have certain health benefits in HD patients. The aim of this study was to investigate the effects of omega-3 fatty acids supplementation on hematocrit (HCT), hemoglobin (HB) level and platelet (PLT) counts of HD patients.</p></div><div><h3>Methods</h3><p>A randomized controlled trial was conducted on HD patients at a private dialysis center in Rasht, Iran. Three omega-3 fatty acid supplement capsules (3 g/d) were administered daily for two months to patients in the intervention group (n = 55). The control group (n = 60) were given three placebo capsules containing medium chain triglyceride (MCT) oil, similar to the supplemental dose of the intervention group at the same period. Three parameters of HCT, HB and PLT were measured at baseline and after the intervention.</p></div><div><h3>Results</h3><p>The PLT count decreased in the intervention group compared to the control group (173.38 ± 74.76 vs. 227.68 ± 86.58 10<sup>3</sup>/mm<sup>3</sup>, F = 4.83, P = 0.03). No significant change was found on the levels of HCT and HB parameters between the two groups after the intervention.</p></div><div><h3>Conclusion</h3><p>Omega-3 supplementation in HD patients may decrease the risk of forming blood clots in the blood vessels. Further studies are warranted.</p></div>","PeriodicalId":36425,"journal":{"name":"Journal of Translational Autoimmunity","volume":"8 ","pages":"Article 100233"},"PeriodicalIF":4.7000,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589909024000030/pdfft?md5=5bcba8760b794c6c65baed779d81fc5c&pid=1-s2.0-S2589909024000030-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Translational Autoimmunity","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589909024000030","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Concomitant inflammation may boost the cardiovascular complications in end-stage renal disease (ESRD) patients undergoing hemodialysis (HD). Omega-3 fatty acids may have certain health benefits in HD patients. The aim of this study was to investigate the effects of omega-3 fatty acids supplementation on hematocrit (HCT), hemoglobin (HB) level and platelet (PLT) counts of HD patients.

Methods

A randomized controlled trial was conducted on HD patients at a private dialysis center in Rasht, Iran. Three omega-3 fatty acid supplement capsules (3 g/d) were administered daily for two months to patients in the intervention group (n = 55). The control group (n = 60) were given three placebo capsules containing medium chain triglyceride (MCT) oil, similar to the supplemental dose of the intervention group at the same period. Three parameters of HCT, HB and PLT were measured at baseline and after the intervention.

Results

The PLT count decreased in the intervention group compared to the control group (173.38 ± 74.76 vs. 227.68 ± 86.58 103/mm3, F = 4.83, P = 0.03). No significant change was found on the levels of HCT and HB parameters between the two groups after the intervention.

Conclusion

Omega-3 supplementation in HD patients may decrease the risk of forming blood clots in the blood vessels. Further studies are warranted.

补充欧米伽-3 脂肪酸对接受透析的 ESRD 患者的血红蛋白、血细胞比容和血小板水平的影响
背景接受血液透析(HD)的终末期肾病(ESRD)患者合并炎症可能会增加心血管并发症。奥米加-3 脂肪酸可能对血液透析患者的健康有一定的益处。本研究旨在调查补充欧米伽-3 脂肪酸对血液透析患者的血细胞比容 (HCT)、血红蛋白 (HB) 水平和血小板 (PLT) 计数的影响。干预组(55 人)每天服用三粒欧米伽-3 脂肪酸补充胶囊(3 克/天),为期两个月。对照组(n = 60)服用三粒含有中链甘油三酯(MCT)油的安慰剂胶囊,剂量与干预组同期的补充剂量相似。结果与对照组相比,干预组的 PLT 计数下降(173.38 ± 74.76 vs. 227.68 ± 86.58 103/mm3,F = 4.83,P = 0.03)。结论HD患者补充omega-3可降低血管内形成血栓的风险。有必要进行进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Translational Autoimmunity
Journal of Translational Autoimmunity Medicine-Immunology and Allergy
CiteScore
7.80
自引率
2.60%
发文量
33
审稿时长
55 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信